Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Deseret Biologicals, Inc. | 43742-2108 | ORAL | 12 [hp_X] in 1 mL | 5/27/2025 | |
| EPIEN Medical Inc | 62942-101 | TOPICAL | 0.3 g in 1 mL | 11/30/2021 | |
| Cantrell Drug Company | 52533-161 | INTRAVENOUS, INTRAMUSCULAR, INTRATHECAL, EPIDURAL | N/A | 5/1/2014 | |
| King Bio Inc. | 57955-2828 | ORAL | 10 [hp_X] in 59 mL | 5/20/2025 | |
| Vsf2 Inc. | 86100-0014 | ORAL | 10 [hp_X] in 59 mL | 8/12/2025 | |
| Cantrell Drug Company | 52533-137 | INTRAVENOUS, INTRATHECAL | N/A | 5/2/2014 | |
| Cantrell Drug Company | 52533-132 | INTRAVENOUS | N/A | 4/28/2014 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| SULFURICUM ACIDUM GOUTTE 2CH-30CH | boiron laboratoires | 00675474 | Drops - Oral | 2 CH / CH | 12/31/1987 |
| KLIMAKTERAN | dr reckeweg and co | 00245836 | Liquid - Oral | 4 X / X | 12/31/1972 |
| HOMEOPATHIC MEDICINE (S89) DPS 30C | total health centre | 02071363 | Drops - Oral | 30 C / ML | 12/31/1994 |
| ACIDUM SULPHURICUM DPS D3-C1000 | thompson's homeopathic supplies ltd. | 00864250 | Drops - Oral | 3 D / D | 12/31/1989 |
| R10 DPS | dr reckeweg canada | 02090864 | Drops - Oral | 6 D / 10 ML | 12/31/1994 |
| INIX | terra botanica products ltd. | 02233337 | Gel - Topical | 12 X | 4/3/1998 |
| ALCOPT | terra botanica products ltd. | 02233287 | Liquid - Oral | 12 X | 5/25/1998 |
| SULFURICUM ACID GLOBULE 2CH-30CH | boiron laboratoires | 00670650 | Tablet - Oral | 2 CH / CH | 12/31/1986 |
| SULFUR ACIDUM GOUTTE 4CH-30CH | dolisos laboratoires s.a. | 00668125 | Drops - Oral | 1 CH / CH | 12/31/1987 |
| SULPHURICUM ACIDUM | homeocan inc. | 02234147 | Granules
,
Drops
,
Globules - Oral | 6 X | 1/6/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.